Where to buy Mobosetinib/Mobosetinib
Mobocertinib/Mobocertinib is a targeted therapy drug targeting epidermal growth factor receptor (EGFR) mutations. It is mainly used to treat patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), especially those carrying EGFR exon 20 insertion mutations. The mechanism of action of this drug is to prevent the proliferation and spread of cancer cells by selectively inhibiting the kinase activity of EGFR. This makes moboxetinib highly effective in the treatment of certain types of non-small cell lung cancer, especially in patients who have failed existing treatment options.

In the domestic market, the original drug of moboxetinib has been approved and marketed, but it is not yet included in the medical insurance system, which makes its price relatively expensive. Taking the 40mg medicine currently on the market as an example, the price of each box of 112 pills is about 40,000 yuan, which is a large expense for many patients. This medicine may be sold in some hospitals or pharmacies.
In addition, generic drugs from many countries and regions are also available in overseas markets. These generic drugs are usually similar in ingredients to the original drugs. For example, the price of 40mg*120 tablets of Mobotinib produced by a pharmaceutical factory in Laos may only cost more than 4,000 yuan, which is much lower than the original drug in the domestic market. However, when purchasing, you need to be aware that exchange rate changes may lead to actual price fluctuations, and you must also ensure that the medicines you purchase are from regular sources and are of reliable quality.
When purchasing moboxetinib, patients should give priority to obtaining the drug through formal channels, such as hospital pharmacies, legal drug suppliers, etc. Especially when it comes to overseas drugs, be sure to confirm the legality of the drug and the qualifications of the supplier to avoid purchasing counterfeit and shoddy products. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)